Leading Growth Driver in the Cell Cryopreservation Market in 2025: Surge In Organ Transplantation Fuels Growth In Cell Cryopreservation Market Driver's Influence

How Are the key drivers contributing to the expansion of the cell cryopreservation market?
The cell cryopreservation market is projected to expand due to the increasing number of organ transplants being performed. In such a medical procedure, a failing or damaged organ is substituted with a healthy one from a donor. The rise in these procedures is attributed to organ malfunction resulting from hereditary anomalies, infections, traumas, and chronic illnesses. Cell cryopreservation plays a crucial role in organ transplantation by preserving the cells of the organ through freezing and storage, intending to maintain their viability for subsequent use - this enhances the success of grafting and diminishes immune rejection. For example, the Health Resources and Services Administration, a federal agency based in the US, reported in January 2024 that in 2023, there were 46,632 organ transplants performed involving both living and deceased donors. This marked an 8.7% increase from 2022 and a 12.7% increase from 2021 - the latter being the first year to see over 40,000 organ transplants. Consequently, the rising prevalence of organ transplant procedures is fuelling the expansion of the cell cryopreservation market.

Get Your Cell Cryopreservation Market Report Here:
https://www.thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report

What growth opportunities are expected to drive the cell cryopreservation market's CAGR through 2034?
The market size for cell cryopreservation has seen exponential growth recently. From $12.65 billion in 2024, it's expected to reach $15.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.3%. The substantial growth observed in the past can be attributed to the escalating demand for cell-based therapies and the surge in biomedical research. Moreover, the rising need for organ transplants, as well as increased research and development activities for cell-based therapies have also fueled market growth. This is furthermore manifested in the expanding utilization of cryopreserved cells.

In the coming years, the cell cryopreservation market is projected to experience substantial growth, reaching $37.01 billion in 2029 with a compound annual growth rate (CAGR) of 23.9%. This anticipated growth during the forecasted period is attributed to the increasing demand for in vitro fertilization (IVF) procedures, the evolution of organ transplant procedures, the extended activities of biobanks, the rising prevalence of chronic illnesses, and the beneficial influence of government initiatives and funding. The forecast period will also witness significant trends such as developments in cryopreservation methods, improvements in MRNA vaccine storage and transport, innovation in cryoprotectants and freezing techniques, a growing preference for personalized medicine, and progress in stem cell research.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15755&type=smp

What are the emerging trends shaping the future of the cell cryopreservation market?
Companies active in the cell cryopreservation market are concentrating on the creation of cryopreservation medium solutions, aiming to provide clients with enhanced features. This solution is essentially a specialized formula that allows for the preservation of cells or tissues by freezing them at extremely low temperatures. This facilitates long-term storage and transport without compromising their functionality and viability. For instance, in April 2024, Pluristyx Inc., a US firm specializing in cellular therapy tools, technologies, and services, introduced its proprietary cryopreservation medium, PluriFreeze, designed to fast-track stem cell therapy development. This solution is specifically targeted towards enhancing the growth of induced pluripotent stem cells (iPSCs) and provides an innovative approach to enhance the efficiency and quality of iPSC therapy development. Pluristyx's PluriFreeze Cryopreservation Media is intended for research use only (RUO) and is designed to simplify the development of stem cell therapy and assist in bringing cell therapies to market.

Which growth-oriented segments of the cell cryopreservation market are leading the industry's development?
The cell cryopreservation market covered in this report is segmented -

1) By Product: Cell Freezing Media, Equipment, Consumables
2) By Application: Hepatocytes, Stem Cells, Oocytes And Embryotic cells, Sperm Cells, Other Applications
3) By End-Use Channel: Biopharmaceutical And Pharmaceutical Companies, Research Institutes, Biobanks, In Vitro Fertilization (IVF) Clinics, Other End-Use Channels

Subsegments:
1) By Cell Freezing Media: Serum-Based Freezing Media, Serum-Free Freezing Media
2) By Cryoprotectants: Cryoprotectants
3) By Equipment: Cryopreservation Freezers, Cryo Storage Tanks, Controlled-Rate Freezers
4) By Consumables: Cryovials, Cryo Storage Bags, Cryo Tubes

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15755

North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What companies are at the forefront of innovation in the cell cryopreservation market?
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc., Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15755&type=smp

What Is Covered In The Cell Cryopreservation Global Market Report?

•Market Size Forecast: Examine the cell cryopreservation market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the cell cryopreservation market for a structured understanding.
•Key Players Overview: Analyze major players in the cell cryopreservation market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell cryopreservation market.
•Segment Contributions: Evaluate how different segments drive overall growth in the cell cryopreservation market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell cryopreservation market.
•Industry Challenges: Identify potential risks and obstacles affecting the cell cryopreservation market.
•Competitive Landscape: Review strategic developments in the cell cryopreservation market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.